Crystal Pharmatech reported that the GMP manufacturing facility of their CDMO business unit, Crystal Formulation Services (CFS), successfully passed a remote audit conducted by a US client. The audit, which lasted for four days, confirmed that CFS’s infrastructure, quality systems, and verification and validation procedures are in compliance with international cGMP standards, laying a solid foundation for the company to provide CDMO services that meets the regulations of the FDA, NMPA, and...